| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 37 | 126 |
-
| | | Gross Profit | (37) | (126) |
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,400 | 1,023 | 1,176 | | Non Recurring |
-
|
-
|
-
| | Others |
-
| 14 | 1 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,437) | (1,164) | (1,178) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (113) | 1,100 | (472) | | Earnings Before Interest And Taxes | (1,408) | (51) | (1,696) | | Interest Expense | 2 | 5 | 1 | | Income Before Tax | (1,410) | (55) | (1,697) | | Income Tax Expense | (178) | (217) |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,373) | 149 | (1,774) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,373) | 149 | (1,774) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,373) | $149 | ($1,774) |
|
0.02% Nasdaq 
0.33%
Income Statement
